Clinical trial NCT04096222 - References

Autoimmune Diseases — Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

Citation(s)

•   Agarwal V, Mittal SK, Misra R
  Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Clin Rheumatol. 2009 Apr;28(4):427-33. doi: 10.1007/s10067-008-1071-1. Epub 2009 Jan 10.
•   Almugairen N, Hospital V, Bedane C, Duvert-Lehembre S, Picard D, Tronquoy AF, Houivet E, D'incan M, Joly P
  Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids. J Am Acad Dermatol. 2013 Oct;69(4):583-8. doi: 10.1016/j.jaad.2013.05.016. Epub 2013 Jul 12.
•   Arakawa M, Dainichi T, Yasumoto S, Hashimoto T
  Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus. J Dermatol Sci. 2009 Mar;53(3):228-31. doi: 10.1016/j.jdermsci.2008.09.008. Epub 2008 Nov 5.
•   Asothai R, Anand V, Das D, Antil PS, Khandpur S, Sharma VK, Sharma A
  Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. Immunobiology. 2015 Oct;220(10):1129-35. doi: 10.1016/j.imbio.2015.06.008. Epub 2015 Jun 17.
•   Baron JM, Höller D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert FK
  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol. 2001 Apr;116(4):541-8.
•   Bauer B, Hartz AM, Miller DS
  Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol. 2007 Mar;71(3):667-75. Epub 2006 Nov 28.
•   Borst P, Elferink RO
  Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537-92. Epub 2001 Nov 9. Review.
•   Bystryn JC, Steinman NM
  The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996 Feb;132(2):203-12. Review.
•   Bystryn JC
  Adjuvant therapy of pemphigus. Arch Dermatol. 1984 Jul;120(7):941-51. Review.
•   Cañete JD, Celis R, Yeremenko N, Sanmartí R, van Duivenvoorde L, Ramírez J, Blijdorp I, García-Herrero CM, Pablos JL, Baeten DL
  Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arthritis Res Ther. 2015 Jul 9;17:173. doi: 10.1186/s13075-015-0688-0.
•   Cholera M, Chainani-Wu N
  Management of Pemphigus Vulgaris. Adv Ther. 2016 Jun;33(6):910-58. doi: 10.1007/s12325-016-0343-4. Epub 2016 Jun 10. Review.
•   Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR
  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem. 1990 Sep;38(9):1277-87.
•   Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR
  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989 Jan;86(2):695-8.
•   de la Fuente H, Baranda L, Hernández MI, Torres-Alvarez B, Llorente L, Layseca E, González-Amaro R
  Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy. J Dermatol Sci. 2002 Apr;28(3):219-26.
•   Diaz-Borjon A, Richaud-Patin Y, Alvarado de la Barrera C, Jakez-Ocampo J, Ruiz-Argüelles A, Llorente L
  Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone Spine. 2000 Jan;67(1):40-8.
•   Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andreeff M, Huber H
  Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood. 1996 Sep 1;88(5):1747-54.
•   Farrell RJ, Murphy A, Long A, Donnelly S, Cherikuri A, O'Toole D, Mahmud N, Keeling PW, Weir DG, Kelleher D
  High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000 Feb;118(2):279-88.
•   Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I
  Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9.
•   Ford JM
  Modulators of multidrug resistance. Preclinical studies. Hematol Oncol Clin North Am. 1995 Apr;9(2):337-61. Review.
•   García-Carrasco M, Mendoza-Pinto C, Macias Díaz S, Vera-Recabarren M, Vázquez de Lara L, Méndez Martínez S, Soto-Santillán P, González-Ramírez R, Ruiz-Arguelles A
  P-glycoprotein in autoimmune rheumatic diseases. Autoimmun Rev. 2015 Jul;14(7):594-600. doi: 10.1016/j.autrev.2015.02.006. Epub 2015 Feb 21. Review.
•   Giordano CN, Sinha AA
  Cytokine networks in Pemphigus vulgaris: An integrated viewpoint. Autoimmunity. 2012 Sep;45(6):427-39. doi: 10.3109/08916934.2012.697593. Epub 2012 Jul 13. Review.
•   Gottesman MM, Pastan I
  Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385-427. Review.
•   Grogan JL, Ouyang W
  A role for Th17 cells in the regulation of tertiary lymphoid follicles. Eur J Immunol. 2012 Sep;42(9):2255-62. doi: 10.1002/eji.201242656. Review.
•   Hartz AM, Bauer B, Fricker G, Miller DS
  Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol. 2006 Feb;69(2):462-70. Epub 2005 Nov 8.
•   Hashimoto N, Nakamichi N, Yamazaki E, Oikawa M, Masuo Y, Schinkel AH, Kato Y
  P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. Int J Pharm. 2017 Apr 15;521(1-2):365-373. doi: 10.1016/j.ijpharm.2017.02.064. Epub 2017 Feb 24.
•   Heaphy MR, Albrecht J, Werth VP
  Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol. 2005 Jun;141(6):699-702.
•   Herbst A, Bystryn JC
  Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol. 2000 Mar;42(3):422-7.
•   Higgins CF
  ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67-113. Review.
•   Horio M, Gottesman MM, Pastan I
  ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci U S A. 1988 May;85(10):3580-4.
•   Ito K, Nguyen HT, Kato Y, Wakayama T, Kubo Y, Iseki S, Tsuji A
  P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin. J Control Release. 2008 Nov 12;131(3):198-204. doi: 10.1016/j.jconrel.2008.08.004. Epub 2008 Aug 12.
•   Johnstone RW, Ruefli AA, Smyth MJ
  Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci. 2000 Jan;25(1):1-6. Review.
•   Kappelmayer J, Karászi E, Telek B, Jakab K
  "Pros and cons" on how to measure multidrug resistance in leukemias. Leuk Lymphoma. 2002 Apr;43(4):711-7. Review.
•   Klimecki WT, Futscher BW, Grogan TM, Dalton WS
  P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood. 1994 May 1;83(9):2451-8.
•   Kneisel A, Hertl M
  Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J Dtsch Dermatol Ges. 2011 Oct;9(10):844-56; quiz 857. doi: 10.1111/j.1610-0387.2011.07793.x. Review. English, German.
•   Liu W, Li H, Zhang D, Lv M, Li Y, Hao Y, Chen Y, Liu X, Xue F, Zhang L, Yang R
  Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia. Autoimmunity. 2016 Nov;49(7):486-495. Epub 2016 Jun 3.
•   Llorente L, Richaud-Patin Y, Díaz-Borjón A, Alvarado de la Barrera C, Jakez-Ocampo J, de la Fuente H, Gonzalez-Amaro R, Diaz-Jouanen E
  Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine. 2000 Jan;67(1):30-9.
•   Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C, Huber H, Hofmann J
  Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol. 1992 Sep;82(1):161-8.
•   Maillefert JF, Maynadie M, Tebib JG, Aho S, Walker P, Chatard C, Dulieu V, Bouvier M, Carli PM, Tavernier C
  Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol. 1996 May;35(5):430-5.
•   Masjedi M, Esmaeil N, Saffaei A, Abtahi-Naeini B, Pourazizi M, Haghjooy Javanmard S, Asilian A
  Cytokine Indexes in Pemphigus Vulgaris: Perception of Its Immunpathogenesis and Hopes for Non-Steroidal Treatment. Iran J Pharm Res. 2017 Summer;16(3):1223-1229.
•   McClean S, Hill BT
  Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug-resistant phenotype in Chinese hamster ovary cells. Eur J Cancer. 1993;29A(16):2243-8.
•   Mortazavi H, Esmaili N, Khezri S, Khamesipour A, Vasheghani Farahani I, Daneshpazhooh M, Rezaei N
  The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. Iran J Allergy Asthma Immunol. 2014 Jun;13(3):174-83.
•   Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, Bystryn JC, Cianchini G, Diaz L, Fivenson D, Hall R, Harman KE, Hashimoto T, Hertl M, Hunzelmann N, Iranzo P, Joly P, Jonkman MF, Kitajima Y, Korman NJ, Martin LK, Mimouni D, Pandya AG, Payne AS, Rubenstein D, Shimizu H, Sinha AA, Sirois D, Zillikens D, Werth VP
  Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008 Jun;58(6):1043-6. doi: 10.1016/j.jaad.2008.01.012. Epub 2008 Mar 14.
•   Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakas A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP
  Diagnosis and management of pemphigus: Recommendations of an international panel of experts. J Am Acad Dermatol. 2020 Mar;82(3):575-585.e1. doi: 10.1016/j.jaad.2018.02.021. Epub 2018 Feb 10.
•   Osman-Ponchet H, Boulai A, Kouidhi M, Sevin K, Alriquet M, Gaborit A, Bertino B, Comby P, Ruty B
  Characterization of ABC transporters in human skin. Drug Metabol Drug Interact. 2014;29(2):91-100. doi: 10.1515/dmdi-2013-0042.
•   Perez-Guerrero EE, Gonzalez-Lopez L, Muñoz-Valle JF, Vasquez-Jimenez JC, Ramirez-Villafaña M, Sanchez-Rodriguez EN, Gutierrez-Ureña SR, Cerpa-Cruz S, Aguilar-Chavez EA, Cardona-Muñoz EG, Vazquez-Villegas ML, Saldaña-Cruz AM, Rodriguez-Jimenez NA, Fajardo-Robledo NS, Gamez-Nava JI
  Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritis. Inflammopharmacology. 2018 Sep 12. doi: 10.1007/s10787-018-0529-2. [Epub ahead of print]
•   Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK
  Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011 Dec 23;35(6):986-96. doi: 10.1016/j.immuni.2011.10.015. Epub 2011 Dec 15.
•   Pfütze M, Niedermeier A, Hertl M, Eming R
  Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol. 2007 Jan-Feb;17(1):4-11. Epub 2007 Feb 27. Review.
•   Pisanti S, Sharav Y, Kaufman E, Posner LN
  Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol. 1974 Sep;38(3):382-7.
•   Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA, McCauley JL, Abreu MT, Unutmaz D, Sundrud MS
  Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med. 2014 Jan 13;211(1):89-104. doi: 10.1084/jem.20130301. Epub 2014 Jan 6.
•   Randolph GJ, Beaulieu S, Pope M, Sugawara I, Hoffman L, Steinman RM, Muller WA
  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6924-9.
•   Richaud-Patin Y, Vega-Boada F, Vidaller A, Llorente L
  Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomed Pharmacother. 2004 Jun;58(5):320-4.
•   Ruiz-Soto R, Richaud-Patin Y, López-Karpovitch X, Llorente L
  Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients. Exp Hematol. 2003 Jun;31(6):483-7.
•   Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T
  Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006 Aug;212:8-27. Review.
•   Schmidt E, Goebeler M, Hertl M, Sárdy M, Sitaru C, Eming R, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A
  S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges. 2015 Jul;13(7):713-27. doi: 10.1111/ddg.12612. English, German.
•   Sinha AA
  Constructing immunoprofiles to deconstruct disease complexity in pemphigus. Autoimmunity. 2012 Feb;45(1):36-43. doi: 10.3109/08916934.2011.606445. Epub 2011 Sep 19. Review.
•   Solís-Arias MP, Rodríguez-Gutiérrez G, Rodríguez-Carreón AA, Vega-Memije E, Domínguez-Soto L
  [Epidemiology of bullous pemphigoid in 32 years]. Gac Med Mex. 2013 May-Jun;149(3):344-8. Spanish.
•   Steinman L
  A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007 Feb;13(2):139-45. Review. Erratum in: Nat Med. 2007 Mar;13(3):385.
•   Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N, Kawamura T, Kitamura R, Ando N, Shimada S
  CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology. 2007;214(3):210-20.
•   Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M
  Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J Immunol. 2008 Jul 15;181(2):1526-35.
•   Timoteo RP, da Silva MV, Miguel CB, Silva DA, Catarino JD, Rodrigues Junior V, Sales-Campos H, Freire Oliveira CJ
  Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Mediators Inflamm. 2017;2017:7151285. doi: 10.1155/2017/7151285. Epub 2017 Feb 22.
•   Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y
  Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis. 2008 Mar;67(3):380-8. Epub 2007 Jul 27.
•   Tsujimura S, Tanaka Y
  Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease. Clin Exp Nephrol. 2012 Feb;16(1):102-8. doi: 10.1007/s10157-011-0520-3. Epub 2011 Aug 17. Review.
•   Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR
  The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun. 1986 Dec 30;141(3):956-62.
•   van de Ven R, Oerlemans R, van der Heijden JW, Scheffer GL, de Gruijl TD, Jansen G, Scheper RJ
  ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol. 2009 Nov;86(5):1075-87. doi: 10.1189/jlb.0309147. Epub 2009 Sep 10. Review.
•   Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT
  Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clin Pharmacokinet. 2015 Jul;54(7):709-35. doi: 10.1007/s40262-015-0267-1. Review.
•   Xu RC, Zhu HQ, Li WP, Zhao XQ, Yuan HJ, Zheng J, Pan M
  The imbalance of Th17 and regulatory T cells in pemphigus patients. Eur J Dermatol. 2013 Nov-Dec;23(6):795-802. doi: 10.1684/ejd.2013.2177.
•   Xu T, Stewart KM, Wang X, Liu K, Xie M, Ryu JK, Li K, Ma T, Wang H, Ni L, Zhu S, Cao N, Zhu D, Zhang Y, Akassoglou K, Dong C, Driggers EM, Ding S
  Metabolic control of T(H)17 and induced T(reg) cell balance by an epigenetic mechanism. Nature. 2017 Aug 10;548(7666):228-233. doi: 10.1038/nature23475. Epub 2017 Aug 2.
•   Xue J, Su W, Chen Z, Ke Y, Du X, Zhou Q
  Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study. Mediators Inflamm. 2014;2014:463928. doi: 10.1155/2014/463928. Epub 2014 May 11.
•   Yuan H, Zhou S, Liu Z, Cong W, Fei X, Zeng W, Zhu H, Xu R, Wang Y, Zheng J, Pan M
  Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis. J Invest Dermatol. 2017 Nov;137(11):2362-2370. doi: 10.1016/j.jid.2017.05.032. Epub 2017 Jun 22.
•   Zhao M, Huang W, Zhang Q, Gao F, Wang L, Zhang G, Su Y, Xiao R, Zhang J, Tang M, Cheng W, Tan Y, Lu Q
  Aberrant epigenetic modifications in peripheral blood mononuclear cells from patients with pemphigus vulgaris. Br J Dermatol. 2012 Sep;167(3):523-31. doi: 10.1111/j.1365-2133.2012.11007.x. Epub 2012 Aug 10.

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

Details for clinical trial NCT04096222